Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript

IRIS INTERNATIONAL INC (IRIS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/20/2012 GN IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer
09/17/2012 GN IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share
07/19/2012 GN IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31
07/17/2012 GN IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation
06/06/2012 GN IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
05/25/2012 GN IRIS International to Present at Upcoming Investor Conferences
05/21/2012 GN IRIS International Unveils NADiA(R) ProsVue(TM) at the American Urological Association (AUA) Annual Meeting, May 19-24, 2012
05/02/2012 GN IRIS International Announces First Quarter 2012 Revenue and Financial Results
04/10/2012 GN IRIS International Reports Granting of Inducement Awards
03/19/2012 GN IRIS International Commences Commercial Shipment of ThermoBrite(R) Elite
03/01/2012 GN IRIS International Announces Fourth Quarter and Full Year 2011 Revenue and Financial Results
02/13/2012 GN IRIS International and Fisher HealthCare Sign Distribution Agreement for ThermoBrite Elite(R) Automated Laboratory Assistant in North America
02/09/2012 GN IRIS to Release Fourth Quarter and Year-End 2011 Financial Results and Host Conference Call and Webcast on Thursday, March 1, 2012
01/12/2012 GN IRIS International Reports Granting of Inducement Awards
12/12/2011 GN IRIS International to Present at Oppenheimer ' Co. Healthcare Conference
12/02/2011 GN IRIS International Provides Preliminary 2012 Guidance at Investor Breakfast December 2nd, 2011 in New York
11/17/2011 GN IRIS International Introduces ThermoBrite Elite(R) at the Association for Molecular Pathology (AMP) 2011 Annual Meeting
10/31/2011 GN IRIS International to Host Investor Breakfast December 2nd, 2011 In New York
10/17/2011 GN IRIS to Release Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 3, 2011
10/14/2011 GN IRIS International Reports Granting of Inducement Awards
09/22/2011 GN IRIS International Receives FDA 510(k) Clearance for Its NADiA ProsVue(TM) Prognostic Cancer Test
07/22/2011 GN IRIS International Reports Granting of Inducement Awards
05/26/2011 GN IRIS to Present at Jefferies 2011 Global Healthcare Conference on June 9, 2011
05/23/2011 GN IRIS International's NADiA(R) ProsVue(TM) Prognostic Prostate Cancer Test Data From Multi-Center Clinical Study Presented at American Urological Association (AUA) 2011 Annual Meeting
05/17/2011 GN IRIS to Hold 2011 Annual Meeting of Stockholders on Friday, May 20, 2011
05/09/2011 GN IRIS International to Present at 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.
04/18/2011 GN IRIS to Release First Quarter Financial Results and Host Conference Call and Webcast on Wednesday, May 4, 2011
04/06/2011 GN IRIS International Begins U.S. Commercial Shipments of iChem(R)VELOCITY(TM) and iRICELL(R) Urinalysis Workstation in March Following Recent FDA 510(k) Clearance
04/04/2011 GN IRIS International and Fujirebio Inc. Sign Joint Development Agreement for IRIS's 3GEMS(TM) Hematology Analyzer Product Line in Japan
03/24/2011 GN IRIS International Receives FDA 510(k) Clearance for Its iChem(R)VELOCITY(TM) Automated Urine Chemistry Analyzer and iRICELL(R) Urinalysis Workstation
03/03/2011 GN IRIS International Awarded Extension of Federal Supply Schedule by U.S. Department of Veteran Affairs
02/28/2011 GN IRIS International Reports Record Revenue for 2010 Fourth Quarter and Full Year
02/24/2011 GN IRIS International's Sample Processing Division Extends Exclusive Supply Agreement With IDEXX Laboratories for an Additional Five Years
02/17/2011 GN IRIS International's NADiA(R)ProsVue(TM) Prognostic Prostate Cancer Test Data From Multi-Center Clinical Study Presented at ASCO 2011 Genitourinary Cancers Symposium
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy